Qiagen Overview

  • Founded
  • 1984
Founded
  • Status
  • Public
  • Employees
  • 5,610
Employees
  • Stock Symbol
  • QGEN
Stock Symbol
  • Investments
  • 53
  • Share Price
  • $46.28
  • (As of Wednesday Closing)

Qiagen General Information

Description

Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates over 85% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (44% of 2020 sales), followed by EMEA (36%) and Asia-Pacific (19%).

Contact Information

Website
www.qiagen.com
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Laboratory Services (Healthcare)
Stock Exchange
NYS
Primary Office
  • QIAGEN Strasse 1
  • 40724 Hilden
  • Germany
+49 02103 000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Qiagen Stock Performance

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$46.28 $46.38 $41.98 - $59.00 $10.6B 228M 811K $1.96

Qiagen Financials Summary

In Thousands,
USD 		TTM 31-Mar-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 12,326,019 13,375,487 8,720,977 8,641,526
Revenue 2,065,455 1,870,346 1,526,424 1,501,848
EBITDA 821,835 705,771 205,754 495,879
Net Income 448,582 359,188 (41,455) 190,380
Total Assets 5,762,610 5,912,530 5,235,616 5,748,332
Total Debt 1,928,951 1,946,199 1,725,091 2,174,206
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Qiagen Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Qiagen‘s full profile, request access.

Request a free trial

Qiagen Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins.
Biotechnology
Hilden, Germany
5,610 As of 2020
00000
0&0

000000 0

labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris ni
000000000 00000 (0000000000)
Waltham, MA
00000 As of 0000
000
00000000 000

00000000

ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum dolore e
0000000000000
San Diego, CA
0000 As of 0000
00000
0.00 0000-00-00
000000&0
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Qiagen Competitors (3)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Thermo Fisher Scientific Formerly PE-Backed Waltham, MA 00000 000 00000000 000
00000000 Formerly VC-backed San Diego, CA 0000 00000 000000&0
0000000 Formerly PE-Backed Madison, WI 0000 00000 000000000000 00000
You’re viewing 3 of 3 competitors. Get the full list »

Qiagen Executive Team (51)

Name Title Board Seat Contact Info
Peer Schatz Chief Executive Officer & Managing Director
Thierry Bernard Chief Executive Officer & Member of the Executive Committee
Roland Sackers Chief Financial Officer & Member of the Executive Committee
Masae Kawamura Senior Director, Medical and Scientific Affairs
Manoj Rao Director, Sales & Director & Head Of Commercial Operations
You’re viewing 5 of 51 executive team members. Get the full list »

Qiagen Board Members (5)

Name Representing Role Since
Elizabeth Tallett Self Board Member 000 0000
Lawrence Rosen Qiagen Chairman of the Supervisory Board & Supervisory Director 000 0000
Stephane Bancel Self Board Member 000 0000
Stéphane Bancel Self Board Member 000 0000
You’re viewing 4 of 5 board members. Get the full list »

Qiagen Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Qiagen Investments & Acquisitions (53)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000000000 17-Sep-2020 000000000000000000 00000 Other Healthcare Technology Systems 0000 000000
000000 07-Jan-2019 000000000 000.00 Outcome Management (Healthcare) 00000 00000000
00000000000 (00000 07-Jan-2019 000000000 00000 00 00000 Buildings and Property 0000 000000
0-00-000 07-Jan-2019 000000000000000000 Other Healthcare Technology Systems 00000000 0000000
STAT-Dx 19-Apr-2018 Merger/Acquisition 00000 Diagnostic Equipment 0000 000000
You’re viewing 5 of 53 investments and acquisitions. Get the full list »

Qiagen Subsidiaries (8)

Company Name Industry Location Founded
Parsagen Diagnostics Diagnostic Equipment Boston, MA 2014
0000000 000000000 Other Healthcare Technology Systems Ann Arbor, MI 0000
0000-00 Diagnostic Equipment Barcelona, Spain 0000
00000000 Other Healthcare Technology Systems Cary, NC 0000
0000000000 Biotechnology Beverly, MA 0000
You’re viewing 5 of 8 subsidiaries. Get the full list »

Qiagen Exits (9)

Company Name Exit Date Exit Type Exit Size Status Buyers
0000000 0000000000 07-Jan-2016 00000 00000 00 0000 Completed
  • 7 buyers
0000000 24-Nov-2014 00000 00000 00 000.00 Completed
  • 10 buyers
0000000 0000000000 12-Mar-2014 00000 00000 00 000.00 Completed
  • 7 buyers
0000000 30-Jan-2012 00000 00000 00 00.00 Completed
  • 3 buyers
Indical Bioscience 01-Jan-2012 Merger/Acquisition Completed
You’re viewing 5 of 9 exits. Get the full list »